Your browser doesn't support javascript.
loading
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial.
Manns, Michael; Samuel, Didier; Gane, Edward J; Mutimer, David; McCaughan, Geoff; Buti, Maria; Prieto, Martín; Calleja, José Luis; Peck-Radosavljevic, Markus; Müllhaupt, Beat; Agarwal, Kosh; Angus, Peter; Yoshida, Eric M; Colombo, Massimo; Rizzetto, Mario; Dvory-Sobol, Hadas; Denning, Jill; Arterburn, Sarah; Pang, Phillip S; Brainard, Diana; McHutchison, John G; Dufour, Jean-François; Van Vlierberghe, Hans; van Hoek, Bart; Forns, Xavier.
Afiliación
  • Manns M; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany; German Center of Infection Research (DZIF), Hannover-Braunschweig, Germany. Electronic address: manns.michael@mh-hannover.de.
  • Samuel D; Centre Hepatobiliaire, Hôpital Paul Brousse, and Université Paris Sud, Villejuif, France.
  • Gane EJ; New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand.
  • Mutimer D; Queen Elizabeth Hospital and NIHR Liver Biomedical Research Unit, Birmingham, UK.
  • McCaughan G; Australian Liver Transplant Unit, Centenary Research Institute, Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.
  • Buti M; Internal Medicine and Hepatology, CIBERHED Vall d'Hebron University Hospital, Barcelona, Spain.
  • Prieto M; Digestive Diseases Service, Hospital Universitario y Politécnico La Fe, and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Valencia, Spain.
  • Calleja JL; Servicio de Gastroenterología y Hepatología Hospital Universitario Puerta de Hierro Universidad Autonoma, Madrid, Spain.
  • Peck-Radosavljevic M; Department of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria.
  • Müllhaupt B; Department for Gastroenterology and Hepatology UniversitätsSpital Zürich, Zürich, Switzerland.
  • Agarwal K; Institute of Liver Studies, King's College Hospital Foundation Trust, London, UK.
  • Angus P; Liver Transplant Unit, Austin Hospital, Heidelberg, VIC, Australia.
  • Yoshida EM; Division of Gastroenterology, Vancouver General Hospital and University of British Columbia, Vancouver, BC, Canada.
  • Colombo M; Department of Gastroenterology, IRCCS Maggiore Hospital University of Milan, Milan, Italy.
  • Rizzetto M; Azienda Ospedaliero-Universitaria, Torino, Italy.
  • Dvory-Sobol H; Gilead Sciences, Foster City, CA, USA.
  • Denning J; Gilead Sciences, Foster City, CA, USA.
  • Arterburn S; Gilead Sciences, Foster City, CA, USA.
  • Pang PS; Gilead Sciences, Foster City, CA, USA.
  • Brainard D; Gilead Sciences, Foster City, CA, USA.
  • McHutchison JG; Gilead Sciences, Foster City, CA, USA.
  • Dufour JF; Department of Hepatology, University of Bern, Bern, Switzerland.
  • Van Vlierberghe H; Ghent University Hospital, Ghent, Belgium.
  • van Hoek B; Department of Gastroenterology and Hepatology, Leiden University Medical Centre, Leiden, Netherlands.
  • Forns X; Liver Unit, Hospital Clinic, CIBEREHD, IDIBAPS, University of Barcelona, Barcelona, Spain.
Lancet Infect Dis ; 16(6): 685-697, 2016 Jun.
Article en En | MEDLINE | ID: mdl-26907736
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Uridina Monofosfato / Bencimidazoles / Hepacivirus / Hepatitis C Crónica / Fluorenos / Cirrosis Hepática Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Ribavirina / Uridina Monofosfato / Bencimidazoles / Hepacivirus / Hepatitis C Crónica / Fluorenos / Cirrosis Hepática Tipo de estudio: Clinical_trials Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Lancet Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2016 Tipo del documento: Article Pais de publicación: Estados Unidos